Your browser doesn't support javascript.
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among HIV-Negative Participants Using Tenofovir/Emtricitabine-Based Preexposure Prophylaxis in 2020: A Substudy of the French National Agency for Research on AIDS and Viral Hepatitis PREVENIR and Inserm SAPRIS-Sero Cohorts.
Delaugerre, Constance; Assoumou, Lambert; Maylin, Sarah; Minier, Marine; Gabassi, Audrey; Genin, Michèle; Beniguel, Lydie; Ghosn, Jade; de Lamballerie, Xavier; El Mouhebb, Mayssam; Costagliola, Dominique; Carrat, Fabrice; Molina, Jean Michel.
  • Delaugerre C; Service de Virologie, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Assoumou L; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Maylin S; Service de Virologie, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Minier M; Service de Virologie, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Gabassi A; Service de Virologie, Hôpital Saint Louis, Assistance Publique-Hôpitaux de Paris, Paris, France.
  • Genin M; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Beniguel L; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Ghosn J; Service de Maladies infectieuses, Hôpital Bichat, Assistance Publique-Hôpitaux de Paris, Infection, Antimicrobials, Modelling, Evolution, Inserm, Université mixte de recherche 1137, Université de Paris, Paris, France.
  • de Lamballerie X; Unité des Virus Emergents, Université Aix Marseille, Institut de recherche pour le développement 190, Inserm U1207, Marseille, France.
  • El Mouhebb M; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Costagliola D; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Carrat F; Sorbonne Université, Inserm, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France.
  • Molina JM; Université de Paris, Inserm, U944, Paris, France.
Open Forum Infect Dis ; 9(7): ofac188, 2022 Jul.
Article in English | MEDLINE | ID: covidwho-1922308
ABSTRACT
The potential preventive efficacy of tenofovir/emtricitabine on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection was assessed in human immunodeficiency virus preexposure prophylaxis (PrEP) users. Prevalence of SARS-CoV-2 immunoglobulin G between May and October 2020 was similar in PrEP users and in a matched population-based cohort, suggesting that tenofovir/emtricitabine has no role in reducing the risk of SARS-CoV-2 acquisition.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: Open Forum Infect Dis Year: 2022 Document Type: Article Affiliation country: Ofid

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study Language: English Journal: Open Forum Infect Dis Year: 2022 Document Type: Article Affiliation country: Ofid